Skip to main content
Figure 2 | Retrovirology

Figure 2

From: Restriction of V3 region sequence divergence in the HIV-1 envelope gene during antiretroviral treatment in a cohort of recent seroconverters

Figure 2

Correlation of the Shannon Entropy with clinical markers of HIV infection. The correlation with (a) the time after seroconversion, (b) the viral load, and (c) the CD4 cell count is shown for 30 subjects at primary infection with HIV. As the time to seroconversion is not known for subject 15, it is not included in (a). Patients were classified into three groups based on the sequence diversity. Group 1 is defined by a low sequence diversity (Shannon Entropy 0–0.75) and is shown as stars. Group 2 is defined by a medium sequence diversity (Shannon Entropy 0.75–1.5) and is shown as triangles. Group 3 is defined by a high sequence diversity (Shannon Entropy > 1.5) and is shown as dots.

Back to article page